Richard Lerner Net Worth & Insider Trades

Richard Lerner - Director, Intra-Cellular Therapies, Inc

As of October 4, 2021

What is Richard Lerner's Net Worth?

The current estimated net worth of Intra-Cellular Therapies, Inc's Director, Richard Lerner, is estimated to be about $4.18M . Richard Lerner owns about 105,243 units of Intra-Cellular Therapies, Inc common stock. In the last 7 years at Intra-Cellular Therapies, Inc, Richard Lerner has sold an estimated value of $177.38K worth.

What is Richard Lerner's Past Insider Trading?

Richard Lerner's largest purchase order was 25,000 units , worth over $68.5K on May 13, 2020. Richard Lerner's largest sale order was 7,000 units , worth over $105.63K on December 13, 2017. In total, Richard Lerner has made about 42 transactions over 7 years of their time at Intra-Cellular Therapies, Inc. Richard Lerner usually trades in October, with the busiest year in 2015, 2020, 2017, 2018 and 2016.

RICHARD LERNER

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Richard Lerner's' Mailing Address?

  • Mailing address is The Scripps Research Institute 10550 N. Torrey Pines Road La Jolla CA 92037 CA

Intra-Cellular Therapies, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Sharon Mates, Ph.D. 2020 $766,800 $690,120 $2,799,998 $1,199,994 $18,767 $5,475,679
Sharon Mates, Ph.D. 2019 $744,500 $759,400 $1,599,996 $1,600,003 $20,661 $4,724,560
Sharon Mates, Ph.D. 2018 $722,800 $585,500 $1,593,735 $1,556,410 $18,024 $4,476,469
Lawrence J. Hineline 2020 $463,400 $222,432 $1,049,984 $449,993 $20,374 $2,206,183
Lawrence J. Hineline 2019 $449,900 $225,000 $749,988 $749,995 $18,648 $2,193,531
Lawrence J. Hineline 2018 $424,400 $203,700 $749,986 $732,430 $17,292 $2,127,808
Suresh Durgam, M.D. 2020 $448,575 $274,400 $599,984 $599,997 $7,385 $1,930,341
Michael I. Halstead 2020 $512,000 $320,000 $1,119,985 $479,990 $17,931 $2,449,906
Michael I. Halstead 2019 $497,100 $323,100 $749,988 $749,995 $17,270 $2,337,453
Michael I. Halstead 2018 $469,000 $225,100 $749,986 $732,430 $16,680 $2,193,196
Mark Neumann 2020 $518,900 $324,312 $1,119,985 $479,990 $130,085 $2,573,272
Mark Neumann 2019 $503,800 $277,100 $799,991 $799,997 $133,449 $2,514,337
Mark Neumann 2018 $106,090 $245,500 $749,995 $749,990 $25,124 $1,876,699
Andrew Satlin, M.D. 2020 $480,634 $0 $1,119,985 $479,990 $20,585 $2,101,194
Andrew Satlin, M.D. 2019 $515,000 $360,500 $874,997 $874,996 $19,332 $2,644,825
Andrew Satlin, M.D. 2018 $500,000 $300,000 $0 $0 $11,792 $811,792
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1567514/000119312521140765/d80913ddef14a.htm

What are Intra-Cellular Therapies, Inc's Past Insider Trades?

Intra-Cellular Therapies, Inc's most recent insider trade came on December 21, 2022 by Joel Marcus who sold 5,000 units worth $254.1K . In the last 8 years, insiders at Intra-Cellular Therapies, Inc have sold an estimated value of $108M and bought an estimated value of $63.62M worth of shares. Insider trading is most common in January, with the busiest year in 2020. The most active traders at the company are Christopher Alafi, Director,  Rory Riggs, Director,  and Robert Nostrand Van, Director .

Intra-Cellular Therapies, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1